Connect Biopharma Holdings Limited Proceeds from Issuance of Private Placement
Connect Biopharma Holdings Limited (CNTB) reported Proceeds from Issuance of Private Placement of $20.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-12
- Connect Biopharma Holdings Limited proceeds from issuance of private placement for the quarter ending 2026-06-30 was $2.67M.
- Connect Biopharma Holdings Limited proceeds from issuance of private placement for the quarter ending 2026-03-31 was $17.48M.
- Connect Biopharma Holdings Limited proceeds from issuance of private placement for the quarter ending 2025-06-30 was $0.00.
- Connect Biopharma Holdings Limited proceeds from issuance of private placement for the quarter ending 2025-03-31 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month |
|---|---|---|---|
| 2026-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $20.15M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $18.60M 10-Q · filed 2026-08-12 | $17.48M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |